UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 6
June-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2406053


Registration ID:
542104

Page Number

a428-a431

Share This Article


Jetir RMS

Title

DEVELOPMENT AND METHOD VALIDATION USING HPLC FOR ASSAY OF ZIPRASIDONE CAPSULE

Abstract

Objective: To develop and validate a novel High-Performance Liquid Chromatography (HPLC) method for the determination and stability analysis of Ziprasidone, an antipsychotic medication used in treating schizophrenia and bipolar disorder. Methods: An HPLC system with a C18 column was utilized, employing a mobile phase of acetonitrile and phosphate buffer (pH 3.0) in a 60:40 v/v ratio. The flow rate was 1.0 mL/min, and detection was at 315 nm. Method validation followed ICH guidelines, assessing linearity, accuracy, precision, specificity, limit of detection (LOD), and limit of quantification (LOQ). Stability studies subjected Ziprasidone to hydrolysis, oxidation, photolysis, and thermal degradation. Results: The HPLC method exhibited excellent linearity over 1-100 μg/mL, with a correlation coefficient (R²) of 0.999. High precision was observed, with intra-day and inter-day relative standard deviations (RSD) below 2%. Accuracy showed recovery rates between 98.5% and 101.2%. The LOD and LOQ were 0.1 μg/mL and 0.3 μg/mL, respectively. Specificity tests indicated no significant interference from excipients and degradation products. Stability studies revealed that Ziprasidone is susceptible to acidic, basic, and oxidative conditions but stable under photolytic and thermal conditions. Conclusion: The developed HPLC method is simple, precise, accurate, and robust for Ziprasidone determination and stability analysis. It is suitable for routine quality control and stability testing of Ziprasidone in pharmaceutical formulations. The stability data ensure the drug's efficacy and safety throughout its shelf life.

Key Words

Ziprasidone, HPLC, Stability study, Method validation, Pharmaceutical analysis

Cite This Article

"DEVELOPMENT AND METHOD VALIDATION USING HPLC FOR ASSAY OF ZIPRASIDONE CAPSULE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 6, page no.a428-a431, June-2024, Available :http://www.jetir.org/papers/JETIR2406053.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"DEVELOPMENT AND METHOD VALIDATION USING HPLC FOR ASSAY OF ZIPRASIDONE CAPSULE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 6, page no. ppa428-a431, June-2024, Available at : http://www.jetir.org/papers/JETIR2406053.pdf

Publication Details

Published Paper ID: JETIR2406053
Registration ID: 542104
Published In: Volume 11 | Issue 6 | Year June-2024
DOI (Digital Object Identifier):
Page No: a428-a431
Country: Ujjain, M.P., India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000143

Print This Page

Current Call For Paper

Jetir RMS